Wild-type mammalian orthoreovirus serotype 3 Dearing (T3wt) is nonpathogenic in humans but preferentially infects and kills cancer cells in culture and demonstrates promising antitumor activity in vivo. Using forward genetics, we previously isolated two variants of reovirus, T3v1 and T3v2, with increased infectivity toward a panel of cancer cell lines and improved in vivo onco-lysis in a murine melanomamodel relative to that of T3wt. Our current study explored howmutations in T3v1 and T3v2 pro-mote infectivity. Reovirions contain trimers of1, the reovirus cell attachment protein, at icosahedral capsid vertices. Quantita-tiveWestern blot analysis showed that purified T3v1 and T3v2 virions had2- and 4-fold-lower levels of1 fiber than did T3wt...
Many viruses invade mucosal surfaces to establish infection in the host. Some viruses are restricted...
Oncolytic viruses are examined to serve as anticancer therapeutics. It is expected that in addition ...
The mammalian orthoreovirus Type 3 Dearing has great potential as oncolytic agent in cancer therapy....
Reovirus preferentially replicates in transformed cells and is being explored as a cancer therapy. I...
The Dearing isolate of Mammalian orthoreovirus (T3D) is a prominent model of virus-host relationship...
BackgroundAlthough the naturally occurring reovirus causes only mild symptoms in humans, it shows co...
Cancer remains to be one of the leading causes of death worldwide. Current treatment methods are not...
BACKGROUND: Although the naturally occurring reovirus causes only mild symptoms in humans, it shows ...
REOviruses (Respiratory Enteric Orphan viruses) are ubiquitous, non-enveloped viruses containing 10 ...
While the mammalian orthoreovirus type 3 dearing (reovirus T3D) infects many different tumour cells,...
Abstract: Viruses that specifically replicate in tumor over normal cells offer promising cancer ther...
Viruses that specifically replicate in tumor over normal cells offer promising cancer therapies. Onc...
Reovirus is under development as a therapeutic for numerous types of cancer. In contrast to other on...
<div><p>Reovirus is a nonenveloped mammalian virus that provides a useful model system for studies o...
The mammalian orthoreovirus Type 3 Dearing has great potential as oncolytic agent in cancer therapy....
Many viruses invade mucosal surfaces to establish infection in the host. Some viruses are restricted...
Oncolytic viruses are examined to serve as anticancer therapeutics. It is expected that in addition ...
The mammalian orthoreovirus Type 3 Dearing has great potential as oncolytic agent in cancer therapy....
Reovirus preferentially replicates in transformed cells and is being explored as a cancer therapy. I...
The Dearing isolate of Mammalian orthoreovirus (T3D) is a prominent model of virus-host relationship...
BackgroundAlthough the naturally occurring reovirus causes only mild symptoms in humans, it shows co...
Cancer remains to be one of the leading causes of death worldwide. Current treatment methods are not...
BACKGROUND: Although the naturally occurring reovirus causes only mild symptoms in humans, it shows ...
REOviruses (Respiratory Enteric Orphan viruses) are ubiquitous, non-enveloped viruses containing 10 ...
While the mammalian orthoreovirus type 3 dearing (reovirus T3D) infects many different tumour cells,...
Abstract: Viruses that specifically replicate in tumor over normal cells offer promising cancer ther...
Viruses that specifically replicate in tumor over normal cells offer promising cancer therapies. Onc...
Reovirus is under development as a therapeutic for numerous types of cancer. In contrast to other on...
<div><p>Reovirus is a nonenveloped mammalian virus that provides a useful model system for studies o...
The mammalian orthoreovirus Type 3 Dearing has great potential as oncolytic agent in cancer therapy....
Many viruses invade mucosal surfaces to establish infection in the host. Some viruses are restricted...
Oncolytic viruses are examined to serve as anticancer therapeutics. It is expected that in addition ...
The mammalian orthoreovirus Type 3 Dearing has great potential as oncolytic agent in cancer therapy....